Echo IQ (ASX: EIQ) chief operating officer Philip Woolff joins Small Caps to discuss the company’s plans to rapidly commercialise its artificial intelligence-based cardiovascular diagnostic technology.

The company was recently selected to take part in the US-based HeartX accelerator program, which helps fast-track deployment of cardiovascular innovations.

To fund the development of its technology, Echo IQ recently raised A$3.27 million and secured a further US$150,000 in funding under the HeartX accelerator program.

Article:
https://smallcaps.com.au/echo-iq-fast-track-us-expansion-ai-cardiovascular-diagnostic-technology/

For more information on Echo IQ:
https://smallcaps.com.au/stocks/EIQ/

See omnystudio.com/listener for privacy information.